Tebra (Kareo) AI Market Strategy Report - Medical Billing Services

Answer Capsule

Tebra (Kareo) holds the second-strongest recommendation position in the Medical Billing Services category, with 34.0% valid recommendation coverage in September 2026, yet the benchmark shows a significant 7.3-point decline from July's 41.3%. The brand's raw mention presence held essentially flat at 58.1%, which means the coverage loss stems from weakening recommendation conversion rather than a discovery problem. The clearest weakness is rank-one erosion, with first-position recommendations falling from 12.3% to 8.7% across the series. The clearest opportunity is recovering top-of-shortlist placement in AI-generated answers where the brand is already present but no longer selected first.

Who This Report Is For

This report is for marketing, growth, and revenue cycle leadership at Tebra (Kareo) who need to understand why AI systems are recommending the brand less often despite stable visibility.

Report Card

Executive Summary

Tebra (Kareo) enters September 2026 as the second-most-recommended brand in the Medical Billing Services category, but the benchmark shows a widening gap to the leader and a narrowing gap to the brands behind it. Valid recommendation coverage fell from 41.3% in July to 34.0% in September, a decline beyond normal variation for the series. The brand recorded 346 present observations and 202 valid recommendations in September, with 249 positive mentions, 97 neutral mentions, and no negative mentions.

The strongest cluster for Tebra (Kareo) is the brand recommendation class covering best medical billing services and top RCM providers, which accounts for all qualified observations in the current public series. The weakest signal is rank-one placement: the brand's rank-one rate fell from 12.3% in July to 8.7% in September, meaning AI systems increasingly name other providers first even when Tebra (Kareo) appears in the answer.

The strongest platform signal is Copilot, where Tebra (Kareo) reaches a 43.75% valid recommendation coverage rate and a 14.06% rank-one rate, outperforming its category-level averages. The clearest platform gap is ChatGPT, where the brand holds a 32.79% coverage rate but a 24.59% top-three rate, indicating that when ChatGPT recommends Tebra (Kareo), it frequently places the brand outside the top three positions.

The core issue is conversion, not visibility. Presence held roughly flat at 58.1% while coverage declined, pointing to a recommendation-stage problem rather than a discovery problem.

What Tebra (Kareo) Is Winning

Questions This Section Answers

• Where does Tebra (Kareo) still hold strong recommendation positions despite the coverage decline?
• How does the brand's Copilot performance compare with its category-level averages?

Tebra (Kareo) retains the second-highest valid recommendation coverage in the category at 34.0%, holding a clear edge over third-place AdvancedMD at 30.6%. The brand also maintains a strong top-three rate of 19.8%, meaning it appears in the top three recommendation positions in nearly one in five qualified observations.

The brand shows particular strength on Copilot, where valid recommendation coverage reaches 43.75%, matching athenahealth's rate on that platform. Tebra (Kareo) also achieves a 14.06% rank-one rate on Copilot, the highest first-position rate the brand records on any tracked platform.

Sentiment framing is another relative strength. Tebra (Kareo) records a net sentiment score of 0.7197 with zero negative mentions across 346 present observations, indicating that AI systems frame the brand positively or neutrally when they reference it.

Where Tebra (Kareo) Has the Clearest AI Visibility Gaps

Questions This Section Answers

• What is driving the gap between Tebra (Kareo)'s presence rate and its valid recommendation coverage?
• Which platforms show the weakest coverage-to-presence conversion for the brand?

The clearest gap is rank-one erosion. Tebra (Kareo)'s rank-one rate fell from 12.3% in July to 8.7% in September, a sharper decline than the overall coverage drop. The brand is increasingly present in AI answers without being named first, which matters because the first recommendation in an AI-generated shortlist carries the strongest buyer attention.

The second gap is recommendation conversion relative to presence. Tebra (Kareo) appears in 58.1% of qualified observations but earns valid recommendation placement in only 34.0%. That gap of roughly 24 points means the brand is mentioned in many answers where it is not actually recommended or shortlisted. The benchmark shows presence held flat while coverage fell, indicating that AI systems are naming Tebra (Kareo) as context or comparison material rather than as a selected option.

The third gap is platform-specific. On ChatGPT, Tebra (Kareo) holds a 32.79% coverage rate but only a 24.59% top-three rate, meaning roughly one in four ChatGPT recommendations places the brand outside the top three. On Perplexity, coverage drops to 18.46%, well below the brand's category average.

The competitive displacement pattern is visible against athenahealth, which leads Tebra (Kareo) by 10.2 percentage points in September, up from 9.0 points in July. As both brands declined, athenahealth's slower pace of decline widened the gap at the top of the category.

Biggest Opportunity

The clearest opportunity for Tebra (Kareo) is recovering rank-one recommendation placement in prompts where the brand is already present but no longer selected first. The benchmark shows presence holding flat while rank-one placement fell from 12.3% to 8.7%, meaning the brand is visible in AI answers but losing the first-position slot to competitors. Because Tebra (Kareo) already appears in 58.1% of qualified observations, the fastest path to stronger recommendation-stage visibility is converting existing mentions into top-of-shortlist placements rather than expanding raw presence. This points to the prompt, page, and citation layers that shape how AI systems rank the brand when they build a shortlist.

Competitive Landscape

Questions This Section Answers

• How does Tebra (Kareo)'s recommendation placement compare with athenahealth's at the top of the category?
• Which lower-coverage competitors still earn stronger placement when recommended?

athenahealth holds dominant recommendation-stage strength in the Medical Billing Services category, with Tebra (Kareo) in second place but losing ground. The table below shows where Tebra (Kareo) sits relative to the tracked competitor set.

Average recommended rank covers rank-eligible recommendations only.

Tebra (Kareo) holds the second-highest top-three rate and rank-one rate in the category, but the gap to athenahealth is substantial: athenahealth reaches rank one nearly 1.5 times more often. The brand's average recommended rank of 2.75 is competitive, though R1 RCM's average rank of 2.5 shows that a lower-coverage brand can still earn stronger placement when recommended.

Prompt Evidence

ChatGPT / Brand Recommendation Prompt: "What are the top 3 EHR systems?" Result: Tebra (Kareo) appears in the response but is not consistently placed in the top three positions, with a 24.59% top-three rate on this platform versus a 32.79% coverage rate.

Copilot / Brand Recommendation Prompt: "What is Kareo used for?" Result: Tebra (Kareo) earns strong recommendation placement, reaching a 43.75% coverage rate and a 14.06% rank-one rate, the brand's strongest platform performance.

Gemini / Brand Recommendation Prompt: "What are the top medical billing services?" Result: Tebra (Kareo) appears in 57.83% of observations but earns valid recommendation placement in only 28.92%, showing a wide gap between presence and recommendation conversion.

Perplexity / Brand Recommendation Prompt: "Best medical billing services for small practices" Result: Tebra (Kareo) is present in 56.92% of observations but earns valid recommendation placement in only 18.46%, the brand's weakest coverage-to-presence conversion among tracked platforms.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map the specific prompts where Tebra (Kareo) appears without earning shortlist placement, identifying which competitors capture the rank-one slot in those answers.

Phase 2: Recommendation Readiness Plan Prioritize the prompt clusters and platform surfaces where rank-one erosion is sharpest, starting with ChatGPT and Perplexity where coverage-to-presence conversion is weakest.

Phase 3: Owned Answer Layer Buildout Develop owned content that answers high-intent medical billing and RCM questions directly, giving AI systems clear, citable material that frames Tebra (Kareo) as a first-choice recommendation.

Phase 4: Citation / Authority Layer Development Strengthen the external source footprint that AI systems use when building shortlists, focusing on third-party comparisons, reviews, and industry analyses that currently favor athenahealth.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track rank-one rate and coverage-to-presence conversion monthly to measure whether recommendation-stage visibility improves, not just raw mention presence.

Why This Matters

Questions This Section Answers

• What does the widening gap between presence and recommendation placement mean for Tebra (Kareo) in AI-driven buyer decisions?

AI-generated answers are becoming the buyer shortlist for medical billing and RCM purchasing decisions. When a practice asks an AI assistant which medical billing service to use, the brands named first in that answer capture the decision moment. Tebra (Kareo) is visible in these answers, but visibility alone is not enough: the benchmark shows the brand appearing in 58.1% of observations while being recommended in only 34.0%, and the gap is widening.

The next move is targeted correction of the prompt, page, and citation layers that determine whether Tebra (Kareo) is named as context or selected as the recommendation. Presence without placement leaves the brand exposed to competitors who convert mentions into shortlist positions.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Tebra (Kareo), the calculation is (249 × 1 + 97 × 0 + 0 × -1) / 346, producing a net sentiment score of 0.7197.

This score matters because unclassified mention counts are misleading. A brand can appear in hundreds of AI answers, but those mentions are not equal: a positive recommendation, a neutral reference, and a competitor-displaced mention carry completely different commercial weight. Share of voice is a diagnostic metric, not a business KPI. Counting all mentions as wins is bad measurement because it treats a brand named as an afterthought the same as a brand named first in a shortlist. Classified sentiment is required before interpreting AI visibility, because it separates genuine recommendation strength from mere presence.

Sentiment by Platform

Methodology

1. Report orientation: This is a benchmark-based AI market strategy report for Tebra (Kareo) in the Medical Billing Services category, produced from the LLM Authority Index AI Market Discovery Index and CiteWorks Studio analysis. It is not a client implementation case study.
2. Reporting window: The primary reporting month is September 2026, with trend comparisons to July 2026 and August 2026 where the public series supports them.
3. Platforms tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode, representing six canonical AI surface families.
4. Observation count: The benchmark collected 800 prompt-surface observations in September 2026, producing 595 qualified observations after relevance and qualification stages.
5. Competitor universe: Ten tracked brands in the Medical Billing Services category, including athenahealth, Tebra (Kareo), AdvancedMD, eClinicalWorks, DrChrono, CareCloud, R1 RCM, CureMD, Greenway Health, and Medusind.
6. Public clusters used: The current public series contains qualified observations only in the brand recommendation class. The pricing and value and multi-brand comparison clusters show zero qualified observations in the public benchmark.
7. Stage 0 role: Raw prompt-surface observations were collected and then passed through relevance filtering and qualification stages before public metrics were calculated. Brand-level percentages use the qualified set as the denominator.
8. Definition of a mention: A mention is any qualified observation where the brand appears in the AI response, regardless of whether the brand is recommended, shortlisted, or merely referenced.
9. Definition of a valid recommendation: A valid recommendation is a qualified observation where the brand appears in a recommendation or shortlist context with rank-eligible placement. Neutral references, cautionary mentions, and comparison-anchor appearances are not counted as valid recommendations.
10. Limitations: The public benchmark does not measure market share, attributable sales, every possible AI response, organic-search ranking, or causality from metric movement alone. Movement between months identifies changes worth investigating but does not establish cause. The current public series does not yet contain qualified observations in pricing or multi-brand comparison classes, limiting analysis of those buyer-intent stages.
11. Ranking interpretation: Top-three rate measures how often a recommended brand appears in the top three positions. Rank-one rate measures how often a recommended brand appears first. Average recommended rank covers rank-eligible recommendations only.
12. Source layer: The benchmark retains prompt-level observations with citations where exposed. Source presence is evidence about the information environment, not automatically proof that a source caused a recommendation.

See How AI Is Recommending Your Brand

The public benchmark shows where Tebra (Kareo) is winning and losing in AI-generated recommendations, but it does not explain which specific prompts, competitors, or evidence sources drive each result. A company-level AI visibility audit maps those patterns into a prioritized strategy for converting presence into shortlist placement.